Searchable abstracts of presentations at key conferences in endocrinology

ea0016p229 | Diabetes and cardiovascular diseases | ECE2008

Retrovirally transduced, antigen-specific T cells for therapy of type 1 diabetes

Mpofu Nonsikelelo , Saal Nadja , Hardtke-Wolenski Matthias , Manns Michael P , Jaeckel Elmar

In vitro expanded antigen specific CD4+CD25+ regulatory T cells (Tregs), have been shown to suppress autoimmune diabetes, suggesting a novel approach to cellular immunotherapy for autoimmunity. However to interfere with ongoing disease requires at least 106 in vitro expanded antigen specific Tregs which are difficult to obtain from a polyclonal repertoire. Hence an alternative approach would be to instruct naïve or antigen specific CD4+T cells to ...

ea0016p230 | Diabetes and cardiovascular diseases | ECE2008

Induction of autoantigen-specific tolerance by retroviral transduction of hematopoetic stem cells with GAD65

Jaeckel Elmar , Ivanyi Philipp , Busch Markus , von Boehmer Harald , Manns Michael P

Transfer of hematopoetic stem cells from mice transgenically overexpressing the islet autoantigen insulin could prevent type I diabetes in NOD mice. We tested if such an approach of tolerance induction could be employed by means of retroviral gene transfer of autoantigens into syngeneic hematopoetic stem cells (HSCs). We used glutamic acid decarboxylase 65 (GAD) as the autoantigen as T cell responses against GAD are more easily detected in NOD mice and as it has been previousl...

ea0016p267 | Endocrine disruptors | ECE2008

New hepatic autoantigens in mice with APS-1 like disease

Hardtke-Wolenski Matthias , Fischer Katja , Anderson Mark , Manns Michael P , Jaeckel Elmar

The AIRE gene (autoimmune regulator) has been identified as an important mediator of central tolerance against ectopically expressed peripheral antigens. Mutatations of AIRE are responsible for autoimmune polyendocrinopathy syndrome type I (APSI) in human characterized by a multiorgan autoimmune disease. Autoimmune hepatitis (AIH) is part of the clinical spectrum in humans and mice. 19% of patients with AIRE mutations develop an autoimmune hepatitis which is characterized by a...